Literature DB >> 17920783

Quantification of mediastinal and hilar lymph node movement using four-dimensional computed tomography scan: implications for radiation treatment planning.

David J Sher1, John A Wolfgang, Andrzej Niemierko, Noah C Choi.   

Abstract

PURPOSE: To quantitatively describe mediastinal and hilar lymph node movement in patients with lymph node-positive lung cancer. METHODS AND MATERIALS: Twenty-four patients with lung cancer who underwent four-dimensional computed tomography scanning at Massachusetts General Hospital were included in the study. The maximum extent of superior motion of the superior border was measured, as well as the maximum inferior movement of the inferior border. The average of these two values is defined as the peak-to-peak movement. This process was repeated for mediolateral (ML) and anterior-posterior (AP) movement. Linear regression was used to determine lymph node characteristics associated with peak-to-peak movement. Various uniform expansions were investigated to determine the expansion margins necessary to ensure complete internal target volume (ITV) coverage.
RESULTS: The mean peak-to-peak displacements of paratracheal lymph nodes were 4 mm (craniocaudal [CC]), 2 mm (ML), and 2 mm (AP). For subcarinal lymph nodes, the mean peak-to-peak movements were 6 mm (CC), 4 mm (ML), and 2 mm (AP). The mean peak-to-peak displacements of hilar lymph nodes were 7 mm (CC), 1 mm (ML), and 4 mm (AP). On multivariate analysis, lymph node station and lymph node size were significantly related to peak-to-peak movement. Expansions of 8 mm for paratracheal nodes and 13 mm for subcarinal and hilar nodes would have been necessary to cover the ITV of 95% of these nodal masses.
CONCLUSIONS: Subcarinal and hilar lymph nodes may move substantially throughout the respiratory cycle. In the absence of patient-specific information on nodal motion, expansions of at least 8 mm, 13 mm, and 13 mm should be considered to cover the ITV of paratracheal, subcarinal, and hilar lymph nodes, respectively.

Entities:  

Mesh:

Year:  2007        PMID: 17920783     DOI: 10.1016/j.ijrobp.2007.05.022

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Tumor, lymph node, and lymph node-to-tumor displacements over a radiotherapy series: analysis of interfraction and intrafraction variations using active breathing control (ABC) in lung cancer.

Authors:  Elisabeth Weiss; Scott P Robertson; Nitai Mukhopadhyay; Geoffrey D Hugo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-22       Impact factor: 7.038

2.  Inferring positions of tumor and nodes in Stage III lung cancer from multiple anatomical surrogates using four-dimensional computed tomography.

Authors:  Kathleen T Malinowski; Jason R Pantarotto; Suresh Senan; Thomas J McAvoy; Warren D D'Souza
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-03       Impact factor: 7.038

3.  Motion-specific internal target volumes for FDG-avid mediastinal and hilar lymph nodes.

Authors:  James M Lamb; Clifford G Robinson; Jeffrey D Bradley; Daniel A Low
Journal:  Radiother Oncol       Date:  2013-09-14       Impact factor: 6.280

4.  Measurement of intra-fraction displacement of the mediastinal metastatic lymph nodes using four-dimensional CT in non-small cell lung cancer.

Authors:  Suzhen Wang; Jianbin Li; Yingjie Zhang; Wei Wang; Fengxiang Li; Tingyong Fan; Min Xu; Qian Shao
Journal:  Korean J Radiol       Date:  2012-06-18       Impact factor: 3.500

5.  Respiratory motion variability of primary tumors and lymph nodes during radiotherapy of locally advanced non-small-cell lung cancers.

Authors:  Nuzhat Jan; Geoffrey D Hugo; Nitai Mukhopadhyay; Elisabeth Weiss
Journal:  Radiat Oncol       Date:  2015-06-14       Impact factor: 3.481

Review 6.  4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CT.

Authors:  Alexander Chi; Nam P Nguyen
Journal:  Front Oncol       Date:  2014-08-04       Impact factor: 6.244

7.  A multimodal image guiding system for Navigated Ultrasound Bronchoscopy (EBUS): A human feasibility study.

Authors:  Hanne Sorger; Erlend Fagertun Hofstad; Tore Amundsen; Thomas Langø; Janne Beate Lervik Bakeng; Håkon Olav Leira
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.